hydrochlorothiazide has been researched along with aliskiren in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 20 (35.09) | 29.6817 |
2010's | 37 (64.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bizot, MN; Denouel, J; Dieterich, HA; Dole, WP; Kemp, C; Vaidyanathan, S; Valencia, J; Yeh, CM; Zhao, C | 1 |
Calhoun, D; Chrysant, SG; Hsu, H; Matrisciano-Dimichino, L; Schober, B; Villamil, A; Zhang, J | 1 |
Barton, J; Dicker, P; Jensen, C; Mulcahy, D; Nussberger, J; O'Brien, E; Stanton, A | 1 |
Aldigier, JC; Azizi, M; Chiang, Y; Januszewicz, A; Pool, JL; Satlin, A; Schmieder, RE; Zidek, W | 1 |
Boye, SW; Engeli, S; Jordan, J; Keefe, DL; Le Breton, S | 1 |
Ashiya, M; Smith, RE | 1 |
Ali, MA; Andersen, K; Constance, CM; Egan, B; Jin, J; Keefe, DL; Weinberger, MH | 1 |
Chrysant, SG; Dattani, D; Hoppe, UC; Hsu, H; Murray, AV; Patel, S; Zhang, J | 1 |
Chrysant, SG | 2 |
Botha, J; Gorostidi, M; Guerediaga, J; Maboudian, M; Philipp, T; Schmieder, RE; Smith, B; van Ingen, H; Weissbach, N | 1 |
Bangalore, S; Messerli, FH | 1 |
Lembo, G; Nickenig, G; Ritter, S; Rodriguez, P; Salko, T; Simanenkov, V; Zhang, J | 1 |
Andersen, K; Blumenstein, M; Calderón, A; Ibram, G; Liu, Z; Romaszko, J; Zhang, J | 1 |
Sureshkumar, KK | 1 |
Baldwin, CM; Plosker, GL | 1 |
Bush, C; Gorostidi, M; Guerediaga, J; Keefe, DL; Philipp, T; Schmieder, RE | 1 |
Barranco, E; Geiger, H; Gorostidi, M; Taylor, A; Xiang, Z; Zhang, J; Zhang, X | 1 |
Savvatis, K; Schultheiss, HP; Tschöpe, C; Westermann, D | 1 |
Chrysant, SG; Dattani, D; Hoppe, UC; Murray, AV; Patel, S; Ritter, S; Zhang, J | 1 |
Benduhn, H; Klebs, S; Schweizer, J; Ulmer, HJ | 1 |
Aguirre Palacios, F; Baschiera, F; Bijarnia, M; Black, HR; Kribben, A; Laflamme, AK | 1 |
Babazadeh, S; Basile, J; Botha, J; Lillestol, M; Weitzman, R; Yurkovic, C | 1 |
Ferdinand, KC; Pool, J; Purkayastha, D; Townsend, R; Weitzman, R | 1 |
Handler, J | 1 |
Dole, WP; Jarugula, V; Papst, CC; Sabo, R; Yan, JH; Zhang, J | 1 |
Oliveira, PR; Rolim, CM; Sangoi, MS; Steppe, M; Wrasse-Sangoi, M | 1 |
Baek, I; Drummond, W; Keefe, DL; Ramos, E; Sirenko, YM | 1 |
Gradman, AH; Keefe, DL; Kolloch, RE; Lederballe, O; Sica, D; Zhang, J | 1 |
Huang, J; Matavelli, LC; Siragy, HM | 1 |
Bhosekar, V; Forker, AD; Keefe, DL; Townsend, RR; Yadao, A | 1 |
Jaimes, EA; Judd, E | 1 |
Fang, H; Konis, G; Lacourcière, Y; Severin, T; Taddei, S; Zhang, J | 1 |
Aguirre P, F; Alessi, T; Baschiera, F; Black, HR; Wright, M | 1 |
Huan, Y; Townsend, R | 1 |
Garcia-Puig, J; Koenig, W; Murray, AV; Patel, S; Uddin, A; Zhang, J | 1 |
Echtay, A; Go, L; Gulzar, T; Haque, KM; Hristoskova, S; Kadwa, M; Maddury, SR; Pande, A | 1 |
Asai, K; Kubota, Y; Mizuno, K; Takahashi, H; Yasutake, M | 1 |
Benitez, FN; Cedenio, H; Giorgi, M; Jaramillo, N; Molina, N; Volman, S; Zilberman, J | 1 |
Adams-Huet, B; Best, SA; Bivens, TB; Fu, Q; Jarvis, SS; Levine, BD; Okada, Y | 1 |
Cao, C; Dong, X; Gao, D; Liu, Y; Niu, X; Song, A; Wei, J; Yan, R | 1 |
Belal, F; El-Enany, N; Walash, M; Zayed, S | 1 |
Agaliotis, GD; Andreadis, EA; Angelopoulos, ET; Kolyvas, GN; Mousoulis, CG; Mousoulis, GP | 1 |
Belal, F; Ebeid, WM; El-Enany, N; Patonay, G; Salim, MM; Walash, M | 1 |
Bosch, J; Copland, I; Dagenais, G; Dans, A; Diaz, R; Joseph, P; Jung, H; Liu, L; Mancia, G; O'Donnell, M; Pfeffer, M; Pogue, J; Teo, KK; Yusuf, S | 1 |
Mannemala, SS; Nagarajan, JS | 1 |
Dimitriadis, GD; Ikonomidis, I; Kotsifaki, EE; Lambadiari, VA; Lekakis, JP; Maratou, EP; Markakis, KP; Mazioti, MC; Raptis, AE; Raptis, SA; Tsirogianni, AG; Vlahakos, DV; Voumvourakis, AN | 1 |
Ebeid, WM; El-Bagary, RI; El-Zaher, AA; Elkady, EF; Patonay, G | 1 |
El-Zeany, BA; Elzanfaly, ES; Hassan, SA; Salem, MY | 2 |
Burnier, M; Forni, V; Hoffman, L; Maillard, M; Milani, B; Muller, ME; Piskunowicz, M; Pruijm, M; Vakilzadeh, N; Zweiacker, C | 1 |
Ahmed, MS; El-Zaher, AA; Mahrouse, MA; Moussa, BA | 1 |
9 review(s) available for hydrochlorothiazide and aliskiren
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Aliskiren-hydrochlorothiazide combination for the treatment of hypertension.
Topics: Amides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Randomized Controlled Trials as Topic; Renin; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; United States; United States Food and Drug Administration | 2008 |
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
Topics: Amides; Animals; Antihypertensive Agents; Drug Therapy, Combination; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Renin; Renin-Angiotensin System; Treatment Outcome | 2008 |
Rational of the use of aliskiren in hypertension and beyond.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Europe; Fumarates; Germany; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Japan; Prevalence; Prorenin Receptor; Protein Precursors; Randomized Controlled Trials as Topic; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Risk Factors; Tetrazoles; Time Factors; World Health Organization | 2009 |
In brief: Another three-drug combination for hypertension.
Topics: Amides; Amlodipine; Animals; Drug Approval; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Tablets; United States | 2011 |
Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Design; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tetrazoles; Valine; Valsartan | 2011 |
Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Treatment Outcome | 2012 |
The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Treatment Outcome | 2012 |
Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
Topics: Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Renin | 2014 |
27 trial(s) available for hydrochlorothiazide and aliskiren
Article | Year |
---|---|
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Topics: Amides; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Least-Squares Analysis; Male; Middle Aged; Renin; Time Factors; Treatment Outcome | 2007 |
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
Topics: Adult; Aged; Aged, 80 and over; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Patient Compliance; Ramipril; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles | 2007 |
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2007 |
Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
Topics: Administration, Oral; Adult; Aged; Amides; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diastole; Double-Blind Method; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Obesity; Renin; Systole; Tetrazoles; Treatment Outcome | 2007 |
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Topics: Administration, Oral; Adult; Amides; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ramipril; Renin; Time Factors; Treatment Outcome | 2008 |
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
Topics: Administration, Oral; Adult; Aged; Amides; Antihypertensive Agents; Double-Blind Method; Dyspepsia; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renin; Single-Blind Method; Time | 2009 |
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.
Topics: Adolescent; Adult; Aged; Amides; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Combinations; Drug Resistance; Endpoint Determination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome; Young Adult | 2008 |
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone.
Topics: Adult; Amides; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Young Adult | 2009 |
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
Topics: Amides; Antihypertensive Agents; Double-Blind Method; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Obesity; Placebos | 2009 |
Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2009 |
Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amides; Antihypertensive Agents; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Incidence; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Young Adult | 2010 |
Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (± amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg.
Topics: Adult; Aged; Algorithms; Amides; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Failure; Treatment Outcome | 2011 |
Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study.
Topics: Aged; Amides; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2010 |
Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study.
Topics: Age Factors; Aged; Amides; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Body Mass Index; Disease Progression; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Health Status Indicators; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Systole; Treatment Outcome; United States | 2011 |
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
Topics: Adult; Amides; Amlodipine; Antihypertensive Agents; Black or African American; Blood Pressure; Brachial Artery; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Headache; Humans; Hydrochlorothiazide; Hypertension; Incidence; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Pharmacokinetics and pharmacodynamics of aliskiren/hydrochlorothiazide single-pill combination tablets and free combination of aliskiren and hydrochlorothiazide.
Topics: Administration, Oral; Adolescent; Adult; Amides; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Least-Squares Analysis; Male; Middle Aged; Models, Biological; Renin; Tablets; Therapeutic Equivalency; Treatment Outcome; Young Adult | 2012 |
Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Topics: Aged; Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Dropouts; Potassium; Single-Blind Method | 2011 |
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renin-Angiotensin System; Time Factors; Young Adult | 2011 |
Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.
Topics: Amides; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renin; Systole | 2011 |
Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
Topics: Aged; Amides; Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Severity of Illness Index; Single-Blind Method | 2012 |
Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick
Topics: Adult; Aged; Amides; Antihypertensive Agents; Blood Pressure; Diastole; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypertension; International Cooperation; Male; Middle Aged; Severity of Illness Index; Systole; Treatment Outcome | 2012 |
Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label study.
Topics: Adult; Aged; Amides; Amlodipine; Antihypertensive Agents; Biological Availability; Blood Pressure; Drug Monitoring; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Pharmacovigilance; Severity of Illness Index; Treatment Outcome | 2012 |
The influence of a direct renin inhibitor on the central blood pressure.
Topics: Adult; Amides; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Prospective Studies; Renin; Time Factors; Treatment Outcome | 2013 |
Chronic renin inhibition lowers blood pressure and reduces upright muscle sympathetic nerve activity in hypertensive seniors.
Topics: Aged; Amides; Antihypertensive Agents; Blood Pressure; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Muscles; Peroneal Nerve; Posture; Renin; Sodium Chloride Symporter Inhibitors; Sympathetic Nervous System | 2013 |
The effect of aliskiren versus ramipril-based treatment on the Ambulatory Arterial Stiffness Index in hypertensive patients.
Topics: Adult; Aged; Amides; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Therapy, Combination; Fumarates; Greece; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Predictive Value of Tests; Ramipril; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Vascular Stiffness; Vasodilator Agents | 2014 |
Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.
Topics: Aged; Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Medication Adherence; Potassium; Treatment Outcome | 2014 |
Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Renin; Single-Blind Method | 2015 |
21 other study(ies) available for hydrochlorothiazide and aliskiren
Article | Year |
---|---|
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Topics: Adolescent; Adult; Amides; Amlodipine; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ramipril; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2006 |
Antihypertensive therapies.
Topics: Amides; Antihypertensive Agents; Blood Pressure; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diuretics; Drug Design; Drug Industry; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Renin; Tetrazoles; Valine; Valsartan | 2007 |
Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
Topics: Aged; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Risk Factors; Tetrazoles; Time Factors; Valine; Valsartan | 2008 |
Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
Topics: Adult; Amides; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Renin | 2008 |
Aliskiren for hypertension in adults.
Topics: Adult; Amides; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Renin; Treatment Outcome | 2008 |
Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark?
Topics: Amides; Antihypertensive Agents; Benchmarking; Fumarates; Humans; Hydrochlorothiazide; Hypertension | 2009 |
Aliskiren/hydrochlorothiazide combination: in mild to moderate hypertension.
Topics: Amides; Antihypertensive Agents; Blood Pressure; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension | 2009 |
Aliskiren + hydrochlorothiazide.
Topics: Amides; Antihypertensive Agents; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension | 2010 |
Managing erectile dysfunction in hypertensive patients.
Topics: Amides; Antihypertensive Agents; Benzopyrans; Chlorthalidone; Ethanolamines; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Impotence, Vasculogenic; Losartan; Male; Middle Aged; Nebivolol; Risk Factors | 2011 |
Simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method.
Topics: Amides; Chromatography, Micellar Electrokinetic Capillary; Fumarates; Hydrochlorothiazide; Pharmaceutical Preparations; Reproducibility of Results | 2011 |
Combined aliskiren and amlodipine reduce albuminuria via reduction in renal inflammation in diabetic rats.
Topics: Albuminuria; Amides; Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fumarates; Hydrochlorothiazide; Inflammation; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin; Streptozocin | 2012 |
Effectiveness and safety of aliskiren and aliskiren hydrochlorothiazide (HCT) in a multiethnic, real-world setting.
Topics: Adult; Amides; Antihypertensive Agents; Asian People; Drug Combinations; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
Use of aliskiren in Latin America in a real-world setting: aliskiren in Latin America Study (ALAS).
Topics: Adult; Aged; Ambulatory Care; Amides; Antihypertensive Agents; Blood Pressure; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Latin America; Male; Middle Aged; Prospective Studies; Renin; Young Adult | 2013 |
Simultaneous determination of aliskiren and hydrochlorothiazide in tablets and spiked human urine by ion-pair liquid chromatography.
Topics: Amides; Antihypertensive Agents; Calibration; Chromatography, High Pressure Liquid; Diuretics; Fumarates; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentration; Indicators and Reagents; Limit of Detection; Quality Control; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets | 2013 |
Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis.
Topics: Amides; Amlodipine; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Fumarates; Hydrochlorothiazide | 2014 |
Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of Aliskiren and Amlodipine in human plasma.
Topics: Acetonitriles; Amides; Amlodipine; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Stability; Fumarates; Humans; Hydrochlorothiazide; Limit of Detection; Sensitivity and Specificity | 2015 |
Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension.
Topics: Aged; Amides; Antihypertensive Agents; Arterial Pressure; Biomarkers; Cells, Cultured; Diabetes Mellitus, Type 2; Diuretics; Drug Substitution; Endothelial Progenitor Cells; Endothelium, Vascular; Female; Fumarates; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pilot Projects; Time Factors; Treatment Outcome; Vascular Stiffness; Vasodilation; Ventricular Function, Left | 2015 |
Simultaneous Determination of Aliskiren Hemifumarate, Amlodipine Besylate and Hydrochlorothiazide in Spiked Human Plasma Using UPLC-MS/MS.
Topics: Amides; Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Fumarates; Humans; Hydrochlorothiazide; Limit of Detection; Liquid-Liquid Extraction; Reproducibility of Results; Tandem Mass Spectrometry | 2015 |
Continuous Wavelet Transform, a powerful alternative to Derivative Spectrophotometry in analysis of binary and ternary mixtures: A comparative study.
Topics: Algorithms; Amides; Amlodipine; Bisoprolol; Complex Mixtures; Fumarates; Hydrochlorothiazide; Reproducibility of Results; Signal Processing, Computer-Assisted; Signal-To-Noise Ratio; Spectrophotometry; Wavelet Analysis | 2015 |
Mean centering of double divisor ratio spectra, a novel spectrophotometric method for analysis of ternary mixtures.
Topics: Amides; Amlodipine; Analysis of Variance; Chromatography, High Pressure Liquid; Fumarates; Hydrochlorothiazide; Methanol; Models, Molecular; Reference Standards; Reproducibility of Results; Spectrophotometry; Tablets | 2016 |
Resolution of overlapped spectra for the determination of ternary mixture using different and modified spectrophotometric methods.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Fumarates; Hydrochlorothiazide; Spectrophotometry, Ultraviolet; Tablets | 2016 |